DEVELOPMENTAL FUNDS

发展基金

• 批准号: 7944866
• 负责人: BRIAN LEYLAND-JONES
• 金额: $ 13.41万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-07 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7944866
• 关键词: ARHGEF5 gene; Address; Area; Bioinformatics; Biological Markers; Breast; Cancer Center; Cancer Center Support Grant; Characteristics; Clinical Trials; Core Facility; Detection; Development; Feedback; Funding; Future; Gene Targeting; Grant; Institutes; Lung; Malignant Neoplasms; Methodology; Mus; Nanotechnology; Organ; Phase; Physicians; Process; Research; Research Personnel; Resources; Scientist; Site; Strategic Planning; Testing; Therapeutic; Transgenic Mice; Translation Process; Translations; Universities; cancer imaging; cohort; health disparity; human subject; malignant breast neoplasm; new technology; oncology; population based; programs; success

Overall Description. As part of the P20 Planning Grant period, key areas of development in the Winship Cancer Institute were identified as part of the strategic planning process. Some major strategic initiatives included: 1) recruitment of researchers and physician-scientists in designated fields of expertise; 2) developmental scientific programs in Breast Cancer and Lung-Aerodigestive Cancers; and 3) two developmental shared core resources - Bioinformatics and Transgenic Mouse and Gene Targeting cores. The successful recruitment of 88 new scientists and clinicians to the WCI in the past five years has largely addressed the first aim. These recruitments are noted in greater detail in "6.0 Six Essential Characteristics of the Cancer Center" and the scientific program areas. The reconfiguration of the WCI scientific programs toward over-arching and uniting themes rather than a focus on organ-site programs has moved the WCI away from previous plans intended to set up the developmental programs in Breast and Lung-Aerodigestive cancers. Third, the need for development of new technologies, such as bioinformatics, and shared core resources remains vital to the future success and advancement of the Winship Cancer Institute. Thus, the Developmental funds as part of the CCSG are being allocated in support of two components: 1) support of new technology and methodologies in Cancer Bioinformatics. and 2) development of a new shared core resource: the Transqenic Mouse and Gene Targeting Core.

总体描述。作为P20计划赠款期的一部分， Winship癌症研究所被确定为战略规划过程的一部分。一些 主要战略举措包括： 1）指定专业领域的研究人员和医师科学家招募； 2）乳腺癌和肺化消化剂癌的发展科学计划；和 3）两个发育共享的核心资源 - 生物信息学和转基因鼠标和基因 靶向核心。 在过去的五个 多年在很大程度上解决了第一个目标。这些招聘在“ 6.0”中更详细地注意到 癌症中心和科学计划领域的六个基本特征。 将WCI科学计划重新配置为超大和团结主题而不是 除了关注器官计划的关注使WCI远离以前的计划 在乳房和肺气区分癌症中设置发展计划。第三，需要 用于开发新技术，例如生物信息学和共享核心资源 对于Winship癌症研究所的未来成功和进步仍然至关重要。因此， 作为CCSG一部分的发展基金正在分配以支持两个组成部分：1） 癌症生物信息学中新技术和方法论的支持。 2）发展 一个新的共享核心资源：跨Qenic鼠标和基因靶向核心。